See All Slides - tctmd.com

Slides

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Presentation TCT 2016

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Ehrin J. Armstrong

November 01, 2016

Presentation TCT 2016

TCTMD Global PCI Map Project

Presenter: Ivan C. Rokos

October 31, 2016

Presentation TCT 2016

My Most Challenging Case 2016: STEMI with Multivessel Disease

Presenter: Shao-Liang Chen, Ajay J. Kirtane, Manish A. Parikh, Bo Xu, Ning Guo

October 31, 2016

Presentation TCT 2016

Treatment of a Rare Complication in the 21st Century

Presenter: Wojtek Wojakowski, Balint Kittka

October 31, 2016

Presentation TCT 2016

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Presenter: Neil E. Moat, John G. Webb, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Use of Intravascular Imaging in CTO Intervention

Presenter: Ik-Kyung Jang, Matthew J. Price, Yasushi Asakura

October 31, 2016

Advertisement

Slides

Subgroup Analyses: How Useful or Harmful Are They?

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR

TCTMD Global PCI Map Project

My Most Challenging Case 2016: STEMI with Multivessel Disease

Treatment of a Rare Complication in the 21st Century

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Use of Intravascular Imaging in CTO Intervention

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content